Factor Therapeutics Ltd operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Factor Therapeutics Ltd with three other
companies in this sector in Australia:
Prima Biomed Limited
sales of 4.22 million Australian Dollars [US$3.19 million]
of which 98%
was Cancer Immunotherapy),
(3.87 million Australian Dollars [US$2.92 million]
of which 53%
was Australia), and
Oncosil Medical Ltd
(3.76 million Australian Dollars [US$2.83 million]
Sales increased substantially in 2017:
During the year ended June of 2017, sales at
Factor Therapeutics Ltd were A$4.02 million (US$3.03 million).
increase of 636.1%
versus 2016, when the company's sales were A$545,868.00 .
This was the third consecutive year of growth at Factor Therapeutics Ltd.